相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP+ and GSH/GSSG ratios and reducing oxidative and inflammatory stress
Selene Angeles Mejia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
NNMT activation can contribute to the development of fatty liver disease by modulating the NAD+ metabolism
Motoaki Komatsu et al.
SCIENTIFIC REPORTS (2018)
Genetic Variants in Nicotinamide-N-Methyltransferase (NNMT) Gene are Related to the Stage of Non-Alcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter (CAP)-FibroScan
Eman M. Hasan et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2018)
De novo NAD+ synthesis enhances mitochondrial function and improves health
Elena Katsyuba et al.
NATURE (2018)
Nicotinamide Adenine Dinucleotide Biosynthesis Promotes Liver Regeneration
Sarmistha Mukherjee et al.
HEPATOLOGY (2017)
Association between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease
Bahareh Amirkalali et al.
MEDICAL PRINCIPLES AND PRACTICE (2017)
Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet
Wenbiao Shi et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS
Gilberto S. Almeida et al.
NMR IN BIOMEDICINE (2017)
Nicotinamide protects hepatocytes against palmitate-induced lipotoxicity via SIRT1-dependent autophagy induction
Chen Shen et al.
NUTRITION RESEARCH (2017)
Eliciting the Mitochondrial Unfolded Protein Response by Nicotinamide Adenine Dinucleotide Repletion Reverses Fatty Liver Disease in Mice
Karim Gariani et al.
HEPATOLOGY (2016)
Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice
Natalie E. de Picciotto et al.
AGING CELL (2016)
Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death
Xiaonan Wang et al.
BRAIN RESEARCH (2016)
Hepatic NAD+ deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing
Can-Can Zhou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease
Zhenghui G. Jiang et al.
LIVER INTERNATIONAL (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice
Hongbo Zhang et al.
SCIENCE (2016)
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Samuel A. J. Trammell et al.
NATURE COMMUNICATIONS (2016)
Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes
Jill L. Sherriff et al.
ADVANCES IN NUTRITION (2016)
Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Samuel A. J. Trammell et al.
SCIENTIFIC REPORTS (2016)
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Lei Shi et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance
Aimo Kannt et al.
DIABETOLOGIA (2015)
Nicotinamide Riboside Ameliorates Hepatic Metaflammation by Modulating NLRP3 Inflammasome in a Rodent Model of Type 2 Diabetes
Hee Jae Lee et al.
JOURNAL OF MEDICINAL FOOD (2015)
Potential Involvement of Nicotinamide N-Methyltransferase in the Pathogenesis of Metabolic Syndrome
Rachela Giuliante et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2015)
Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet
Melanie Penke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization
Shangyu Hong et al.
NATURE MEDICINE (2015)
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
Joseph J. Lee et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites
Witigo von Schoenfels et al.
LIVER INTERNATIONAL (2015)
The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome
Annabelle Z. Caron et al.
FASEB JOURNAL (2014)
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity
Daniel Kraus et al.
NATURE (2014)
Molecular pathways in non-alcoholic fatty liver disease
Alba Berlanga et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2014)
Change in mRNA expression of sirtuin 1 and sirtuin 3 in cats fed on high fat diet
Shingo Ishikawa et al.
BMC VETERINARY RESEARCH (2013)
Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease
Teresa Auguet et al.
CLINICAL BIOCHEMISTRY (2013)
NAD+ metabolism: A therapeutic target for age-related metabolic disease
Laurent Mouchiroud et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38 Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome
Carlos Escande et al.
DIABETES (2013)
Association of Nicotinamide-N-Methyltransferase Gene rs694539 Variant with Patients with Nonalcoholic Steatohepatitis
Ali Sazci et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Circadian Clock NAD+ Cycle Drives Mitochondrial Oxidative Metabolism in Mice
Clara Bien Peek et al.
SCIENCE (2013)
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
Seung-Hoi Koo
CLINICAL AND MOLECULAR HEPATOLOGY (2013)
The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
Caries Canto et al.
CELL METABOLISM (2012)
Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety
Rahul Yadav et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
Xin Luo et al.
GENES & DEVELOPMENT (2012)
Sirtuins as regulators of metabolism and healthspan
Riekelt H. Houtkooper et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells
Sarah C. Bowlby et al.
PLOS ONE (2012)
Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation
Agnieszka A. Kendrick et al.
BIOCHEMICAL JOURNAL (2011)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice
Jun Yoshino et al.
CELL METABOLISM (2011)
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
Peter Bai et al.
CELL METABOLISM (2011)
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
Yu-Hung Chang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
D. Friebe et al.
DIABETOLOGIA (2011)
Hepatic FoxOs Regulate Lipid Metabolism via Modulation of Expression of the Nicotinamide Phosphoribosyltransferase Gene
Rongya Tao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus
Hala O. El-Mesallamy et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
Martina Lukasova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes
A. Garten et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Clocks in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging
Shin-ichiro Imai
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
Riekelt H. Houtkooper et al.
ENDOCRINE REVIEWS (2010)
Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease
Tuva B. Dahl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
Radhika Gaddipati et al.
ANNALS OF HEPATOLOGY (2010)
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Nicotinic acid nicotinamide and nicotinamide riboside: A molecular evaluation of NAD(+) precursor vitamins in human nutrition
Katrina L. Bogan et al.
ANNUAL REVIEW OF NUTRITION (2008)
The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control
Yasukazu Nakahata et al.
CELL (2008)
SIRT1 regulates circadian clock gene expression through PER2 deacetylation
Gad Asher et al.
CELL (2008)
Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects: Response to Musso et al.
S. Sookoian et al.
DIABETES CARE (2008)
Sirt1 protects against high-fat diet-induced metabolic damage
Paul T. Pfluger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Metabolic adaptations through the PGC-1α and SIRT1 pathways
Joseph T. Rodgers et al.
FEBS LETTERS (2008)
SIRT1 transgenic mice show phenotypes resembling calorie restriction
Laura Bordone et al.
AGING CELL (2007)
Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme
Javier R. Revollo et al.
CELL METABOLISM (2007)
The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity
Maria Thereza P. Barbosa et al.
FASEB JOURNAL (2007)
Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival
Hongying Yang et al.
CELL (2007)
Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway
Masaki Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A high-fat, ketogenic diet induces a unique metabolic state in mice
Adam R. Kennedy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Nampt/PBEF/Visfatin: A regulator of mammalian health and longevity?
Hongying Yang et al.
EXPERIMENTAL GERONTOLOGY (2006)
Regulation of intracellular levels of NAD: A novel role for CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
William C. Hallows et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2α deacetylase activity
JB Pillai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction
G Cipriani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Calorie restriction extends yeast life span by lowering the level of NADH
SJ Lin et al.
GENES & DEVELOPMENT (2004)
Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state
M Fulco et al.
MOLECULAR CELL (2003)
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis
G Musso et al.
HEPATOLOGY (2003)
Safety of high dose nicotinamide: a review
M Knip et al.
DIABETOLOGIA (2000)
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
S Imai et al.
NATURE (2000)
分享论文
